EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Diverse Obesity Trajectories in a Family Including Identical Twins with a Pathogenic MC4R Variant

Jane Jia Xin Lim, Amanda J Hooper, Joan Khoo, Wann Jia Loh

Obesity Facts · 2025

DOI: 10.1159/000546795 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Obesity Facts, 2025. Verfasst von Jane Jia Xin Lim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Changi General Hospital, Singapore, Singapore, jane.lim94@gmail.com. Hauptthemen laut MEDLINE: Obesity, Receptor, Melanocortin, Type 4. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pathogenic heterozygous melanocortin-4 receptor (MC4R) variants are the most common cause of monogenic obesity, affecting central satiety and appetite regulatory areas of the brain. Case Presentations: We report a pedigree with a pathogenic MC4R variant (c.380C>T, p.Ser127Leu). In the proband with obesity (BMI 35 kg/m2) and severe insulin resistance, use of combination of semaglutide and naltrexone-bupropion was successful in reducing insulin requirements and weight. His adult monozygotic twin daughters both had childhood-onset obesity; however, weight trajectories differed. Twin 1 had a peak BMI of 29.1 kg/m2, which decreased to 19.7 kg/m2 with intensive exercise and diet control without weight-lowering medication. Twin 2 had a sedentary lifestyle and epilepsy and had a peak BMI of 30.1 kg/m2; she responded well to naltrexone-bupropion and BMI decreased to 26 kg/m2.

Conclusion

The manifestation of obesity, even in cases of monogenic obesity, can vary significantly due to the influence of environmental and lifestyle factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityReceptor, Melanocortin, Type 4AdultFemaleHumansMaleBody Mass IndexInsulin ResistancePedigreeTwins, MonozygoticMiddle Aged

Stichwörter der Autor:innen

GLP-1-RAMC4R mutationMonogenetic obesityNaltrexone-bupropionSemaglutide

Substanzen

MC4R protein, humanReceptor, Melanocortin, Type 4

Autor:innen und Institutionen

  • Department of Endocrinology, Changi General Hospital, Singapore, Singapore, jane.lim94@gmail.com.
  • Department of Biochemistry, PathWest Laboratory Medicine, Royal Perth Hospital and Fiona Stanley Hospital Network, Perth, Washington, Australia.
  • School of Medicine, University of Western Australia, Perth, Washington, Australia.
  • Department of Endocrinology, Changi General Hospital, Singapore, Singapore.
  • Duke-NUS Medical School, Singapore, Singapore.

Zitieren

APA

Lim, J. J. X., Hooper, A. J., Khoo, J., & Loh, W. J. (2025). Diverse Obesity Trajectories in a Family Including Identical Twins with a Pathogenic MC4R Variant. Obesity Facts. https://doi.org/10.1159/000546795

Vancouver

Lim JJX, Hooper AJ, Khoo J, Loh WJ. Diverse Obesity Trajectories in a Family Including Identical Twins with a Pathogenic MC4R Variant. Obesity Facts. 2025. doi:10.1159/000546795

BibTeX
@article{Lim2025,
  author = {Lim, Jane Jia Xin and Hooper, Amanda J and Khoo, Joan and Loh, Wann Jia},
  title = {Diverse Obesity Trajectories in a Family Including Identical Twins with a Pathogenic MC4R Variant},
  journal = {Obesity Facts},
  year = {2025},
  doi = {10.1159/000546795}
}
Kostenlos starten →